Science Explorer Interactive view Map
Topic · Oncology

Pancreatic and Hepatic Oncology Research

Pancreatic and Hepatic Oncology Research is a research topic within Oncology. Science Explorer counts 69k research works in it since 1950. 14.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the research and treatment of pancreatic cancer, covering topics such as surgical complications, chemotherapy regimens (e.g., Gemcitabine), tumor microenvironment, genomic analyses, stromal biology, neoadjuvant therapy, and immunotherapy. The papers also discuss the impact of hospital volume on surgical outcomes and the prevalence of pancreatic cysts.

  • Pancreatic Cancer
  • Surgical Complications
  • Gemcitabine
  • Tumor Microenvironment
  • Genomic Analyses
  • Chemotherapy
  • Stromal Biology
  • Neoadjuvant Therapy
  • Metastatic Pancreatic Cancer
  • Immunotherapy
Research works
69k
fractional, since 1950
In the world top 10%
10k
per year above
Top-10% rate
14.9%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+41%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Pancreatic and Hepatic Oncology Research research?

By volume, the United States and China publish the most (3.6k and 2.8k works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 3.6k works
  2. 2 China 2.8k works
  3. 3 Japan 1.5k works
  4. 4 Italy 745 works
  5. 5 India 631 works
  6. 6 Germany 599 works
  7. 7 United Kingdom 575 works
  8. 8 South Korea 512 works
  9. 9 Spain 425 works
  10. 10 France 371 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 30.3%China: 23.9%Japan: 12.9%Italy: 6.3%6 others listed: 26.5%30%largest
United States3,559 · 30.3%China2,812 · 23.9%Japan1,517 · 12.9%Italy745 · 6.3%6 others listed3,112 · 26.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Pancreatic and Hepatic Oncology Research research?

By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Pancreatic and Hepatic Oncology Research research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and University of Verona.

By volume, 2022–2025

  1. 1 The University of Texas MD Anderson Cancer CenterUnited States 115 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 86 works
  3. 3 University of VeronaItaly 66 works
  4. 4 Memorial Sloan Kettering Cancer CenterUnited States 61 works
  5. 5 Johns Hopkins UniversityUnited States 58 works
  6. 6 Sun Yat-sen UniversityChina 52 works
  7. 7 Sichuan UniversityChina 52 works
  8. 8 The Ohio State University Wexner Medical CenterUnited States 52 works
  9. 9 Peking Union Medical College HospitalChina 47 works
  10. 10 Nanjing Medical UniversityChina 44 works

Who are the leading researchers in Pancreatic and Hepatic Oncology Research?

The most-cited researchers publishing on Pancreatic and Hepatic Oncology Research include Thomas D. Schmittgen, Bert Vogelstein and Reza Malekzadeh.

  1. 1 Thomas D. Schmittgen United States 19k citations
  2. 2 Bert Vogelstein United States 7.1k citations
  3. 3 Reza Malekzadeh Iran 6.7k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Pancreatic and Hepatic Oncology Research research done?

The largest centres of Pancreatic and Hepatic Oncology Research research in 2022–2025 are Beijing (China), Shanghai (China), Tokyo (Japan) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Rozzano, Verona and Wakayama.

Largest cities, 2022–2025

  1. 1 Beijing China 359 works
  2. 2 Shanghai China 335 works
  3. 3 Tokyo Japan 323 works
  4. 4 Seoul South Korea 287 works
  5. 5 New York United States 207 works
  6. 6 Guangzhou China 189 works
  7. 7 Houston United States 165 works
  8. 8 Hangzhou China 152 works
  9. 9 Nanjing China 144 works
  10. 10 London United Kingdom 143 works

Where it is the local speciality

  1. RozzanoIT · 42.4 works19×
  2. VeronaIT · 70.3 works18×
  3. WakayamaJP · 24.6 works17×
  4. KashiwaJP · 21.1 works16×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Pancreatic and Hepatic Oncology Research than the world average.

See Pancreatic and Hepatic Oncology Research on the map

Where is the best place to study Pancreatic and Hepatic Oncology Research?

Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Carol Davila University of Medicine and Pharmacy and Vita-Salute San Raffaele University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 19.53%fractional works in this node (log) →share in the world top 10% →Chinese Academy of Medical Sciences & Peking Union Medical College: 86, 20.3%Carol Davila University of Medicine and Pharmacy: 20, 20.8%Vita-Salute San Raffaele University: 35, 17.9%Humanitas University: 20, 18.5%Shanghai Medical College of Fudan University: 16, 20.5%Nara Medical University: 13, 20.9%University of Verona: 66, 12.5%Nanjing Medical University: 44, 18.9%Dalian Medical University: 21, 28.0%Second Military Medical University: 31, 17.0%Carol Davila Univers…Chinese Academy of M…Humanitas UniversityVita-Salute San Raff…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 61.920.3%6.1×86 +156.1%
2 Carol Davila University of Medicine and PharmacyRomania 61.120.8%8.7×20 +422.2%
3 Vita-Salute San Raffaele UniversityItaly 61.017.9%18.5×35 +79.4%
4 Humanitas UniversityItaly 60.318.5%17.4×20 +123.3%
5 Shanghai Medical College of Fudan UniversityChina 59.020.5%14.0×16 +144.0%
6 Nara Medical UniversityJapan 58.820.9%13.1×13 +177.7%
7 University of VeronaItaly 57.412.5%19.2×66 +24.1%
8 Nanjing Medical UniversityChina 54.818.9%6.0×44 +152.6%
9 Dalian Medical UniversityChina 54.728.0%7.7×21 +59.0%
10 Second Military Medical UniversityChina 52.817.0%18.6×31 +16.6%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Pancreatic and Hepatic Oncology Research research growing?

Output in 2018–2022 was 41% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Pancreatic and Hepatic Oncology Research.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.